KR950005309A - 양호한 용해 특성을 갖는 제약 조성물 - Google Patents

양호한 용해 특성을 갖는 제약 조성물 Download PDF

Info

Publication number
KR950005309A
KR950005309A KR1019940018899A KR19940018899A KR950005309A KR 950005309 A KR950005309 A KR 950005309A KR 1019940018899 A KR1019940018899 A KR 1019940018899A KR 19940018899 A KR19940018899 A KR 19940018899A KR 950005309 A KR950005309 A KR 950005309A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
salt
weight percent
cellulose
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019940018899A
Other languages
English (en)
Korean (ko)
Inventor
닉파르 파라나크
티. 엠. 세라주딘 아부
엘. 제르쥬스키 로버트
비. 자인 네미챈드
Original Assignee
니콜라스 피. 말라테스티닉
브리스톨-마이어즈 스퀴브 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 니콜라스 피. 말라테스티닉, 브리스톨-마이어즈 스퀴브 캄파니 filed Critical 니콜라스 피. 말라테스티닉
Publication of KR950005309A publication Critical patent/KR950005309A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019940018899A 1993-08-02 1994-07-30 양호한 용해 특성을 갖는 제약 조성물 Withdrawn KR950005309A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10080293A 1993-08-02 1993-08-02
US8/100,802 1993-08-02

Publications (1)

Publication Number Publication Date
KR950005309A true KR950005309A (ko) 1995-03-20

Family

ID=22281616

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940018899A Withdrawn KR950005309A (ko) 1993-08-02 1994-07-30 양호한 용해 특성을 갖는 제약 조성물

Country Status (15)

Country Link
EP (1) EP0638310A1 (enExample)
JP (1) JPH07145052A (enExample)
KR (1) KR950005309A (enExample)
CN (1) CN1118254A (enExample)
AU (1) AU6878294A (enExample)
CA (1) CA2129099A1 (enExample)
CZ (1) CZ181094A3 (enExample)
FI (1) FI943569A7 (enExample)
HU (1) HUT70951A (enExample)
IL (1) IL110376A (enExample)
NO (1) NO942854L (enExample)
NZ (1) NZ264129A (enExample)
PL (1) PL304508A1 (enExample)
RU (1) RU94028273A (enExample)
ZA (1) ZA945672B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160101720A (ko) * 2014-01-02 2016-08-25 아스트라제네카 아베 Azd9291을 포함하는 제약 조성물

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839526A3 (en) * 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with fast buccal disintegration or dissolution
CN1195500C (zh) 1998-05-18 2005-04-06 武田药品工业株式会社 可口腔崩解的片剂
CA2581111A1 (en) 1998-07-28 2000-02-10 Takeda Pharmaceutical Company Limited Rapidly disintegrable solid preparation
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
JP4698000B2 (ja) * 2000-06-27 2011-06-08 旭化成ケミカルズ株式会社 水易溶性薬物含有錠剤
WO2002072069A1 (en) * 2001-03-12 2002-09-19 Novo Nordisk A/S Novel tablets and capsules and a process for its preparation
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
DE10341414A1 (de) * 2003-09-05 2005-03-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Oral zu applizierende Darreichungsform für schwerlösliche saure und amphotere Wirkstoffe
CN100438914C (zh) * 2003-10-15 2008-12-03 富士化学工业株式会社 用于口腔内快速崩解的片剂的组合物
JP3841804B2 (ja) 2003-10-15 2006-11-08 富士化学工業株式会社 口腔内速崩壊性錠剤用の組成物
US8349361B2 (en) 2003-10-15 2013-01-08 Fuji Chemical Industry Co., Ltd. Composition for rapid disintegrating tablet in oral cavity
EA015304B1 (ru) 2006-08-03 2011-06-30 Нитек Фарма Аг Лечение ревматоидного заболевания глюкокортикоидами с отсроченным высвобождением
MY149356A (en) 2007-03-29 2013-08-30 Daiichi Sankyo Co Ltd Pharmaceutical composition
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
EP3804717A1 (en) 2014-05-16 2021-04-14 Cumberland Pharmaceuticals, Inc. Compositions and methods of treating systemic sclerosis or pulmonary arterial hypertension
US12161632B2 (en) 2014-05-16 2024-12-10 Cumberland Pharmaceuticals Inc. Compositions and methods of treating cardiac fibrosis with ifetroban
MX2017017155A (es) 2015-06-30 2018-08-09 Cumberland Pharmaceuticals Inc Antagonistas del receptor de tromboxano en erea/asma.
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
CN109310646A (zh) 2016-05-05 2019-02-05 阿奎斯蒂弗医疗股份有限公司 增强递送的肾上腺素组合物
EP3454850B1 (en) 2016-05-11 2023-06-21 Cumberland Pharmaceuticals Inc. Compositions and methods of treating muscular dystrophy with thromboxane-a2 receptor antagonists
US12465564B2 (en) 2021-10-25 2025-11-11 Aquestive Therapeutics, Inc. Oral and nasal compositions and methods of treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100889A (en) * 1989-04-03 1992-03-31 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
DD299186A5 (de) * 1990-10-01 1992-04-02 E.R. Squibb U. Sons,Inc.,Us Phenylen-7-oxabicycloheptyl-substituierte heterocycloamid-prostaglandinanaloga

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160101720A (ko) * 2014-01-02 2016-08-25 아스트라제네카 아베 Azd9291을 포함하는 제약 조성물

Also Published As

Publication number Publication date
CN1118254A (zh) 1996-03-13
EP0638310A1 (en) 1995-02-15
CZ181094A3 (en) 1995-02-15
AU6878294A (en) 1995-02-09
CA2129099A1 (en) 1995-02-03
NO942854L (no) 1995-02-03
RU94028273A (ru) 1996-11-10
FI943569L (fi) 1995-02-03
IL110376A0 (en) 1994-10-21
FI943569A7 (fi) 1995-02-03
FI943569A0 (fi) 1994-07-29
HU9402254D0 (en) 1994-09-28
IL110376A (en) 1998-08-16
NO942854D0 (enExample) 1994-08-01
NZ264129A (en) 1996-05-28
PL304508A1 (en) 1995-02-06
JPH07145052A (ja) 1995-06-06
ZA945672B (en) 1995-03-06
HUT70951A (en) 1995-11-28

Similar Documents

Publication Publication Date Title
KR950005309A (ko) 양호한 용해 특성을 갖는 제약 조성물
US5180589A (en) Pravastatin pharmaceuatical compositions having good stability
US5030447A (en) Pharmaceutical compositions having good stability
US6174548B1 (en) Omeprazole formulation
AU2002301782B8 (en) Clopidogrel bisulfate tablet formulation
CA2265766C (en) Rapidly disintegrating pellets
CA2639407C (en) Pharmaceutical compositions comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof
US5807580A (en) Film coated tablet compositions having enhanced disintegration characteristics
US6106862A (en) Once daily analgesic tablet
US4789549A (en) Sustained release dosage forms
CA2452738A1 (en) Gastric retention controlled drug delivery system
CA2323102A1 (en) Monolithic tablet for controlled drug release
KR880008805A (ko) 활성물질을 지속적으로 방출할 수 있는 약제용 정제
GB2207353A (en) Controlled release formulation
RU96116411A (ru) Быстро распадающаяся готовая препаративная форма трамадола или соли трамадола
US4925676A (en) Extended release gemfibrozil composition
WO2008023390B1 (en) Modified release pharmaceutical composition of bupropion hydrochloride
JP2002316928A (ja) コーティング錠及びコーティング錠のはがれを防止する方法
CA2449998A1 (en) Stable controlled release pharmaceutical compositions containing pravastatin
EP1300160A1 (en) Method of stabilizing preparation
JPS6048484B2 (ja) 拡散性活性剤デイスペンサ−
KR0142435B1 (ko) 양호한 안정성을 갖는 제약 조성물
JP2008074770A (ja) 臭いの防止された固形医薬製剤の製造方法、及びそれにより得られる固形医薬製剤
KR900011455A (ko) 활성제의 서방형 제제 및 그 제조방법
DK158563B (da) Tetracyklin-tabletter der ikke beskadiger spiseroeret

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19940730

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid